| 摘要 |
Therapeutic process for treating panic disorders in humans comprising, the systemic administration of a 8-chloro-1-[(dimethylamino)-methyl]-6-phenyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine including the N-oxides and pharmacologically acceptable acid addition salts thereof in combination with a pharmaceutical carrier.
|
